About Medizinische Hochschule Hannover, Zentrum Innere Medizin
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
2
HepNet Study House, German Liverfoundation
2
Gerhard Treiber
1
Clinical Trials at Medizinische Hochschule Hannover, Zentrum Innere Medizin
During the past decade, Medizinische Hochschule Hannover, Zentrum Innere Medizin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001
2008-10-01
2012-04-01
Completed
33
Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
2008-11-01
2013-08-01
Terminated
99
HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis
2009-06-01
2017-08-02
Completed
70
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
2015-12-30
2023-12-31
Active, not recruiting
319
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)
2016-06-03
2021-12-27
Completed
213
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Hochschule Hannover, Zentrum Innere Medizin"
#1 collaborator was "Hannover Medical School" with 2 trials as a collaborator, "Crolll Gmbh" with 1 trials as a collaborator, "Estimate, GmbH" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Medizinische Hochschule Hannover, Zentrum Innere Medizin
According to Clinical.Site data, the most researched conditions in "Medizinische Hochschule Hannover, Zentrum Innere Medizin" are
"Hepatitis C, Chronic" (1 trials), "Hepatitis D" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Isocitrate Dehydrogenase" (1 trials) and "Leukemia, Myeloid" (1 trials). Many other conditions were trialed in "Medizinische Hochschule Hannover, Zentrum Innere Medizin" in a lesser frequency.
Clinical Trials Intervention Types at Medizinische Hochschule Hannover, Zentrum Innere Medizin
Most popular intervention types in "Medizinische Hochschule Hannover, Zentrum Innere Medizin" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (2 trials), "AG-221" (1 trials), "BSC" (1 trials), "Durvalumab" (1 trials) and "Everolimus, Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medizinische Hochschule Hannover, Zentrum Innere Medizin
The vast majority of trials in "Medizinische Hochschule Hannover, Zentrum Innere Medizin" are
5 trials for "All" genders.
Clinical Trials Status at Medizinische Hochschule Hannover, Zentrum Innere Medizin
Currently, there are NaN active trials in "Medizinische Hochschule Hannover, Zentrum Innere Medizin".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Medizinische Hochschule Hannover, Zentrum Innere Medizin,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Hochschule Hannover, Zentrum Innere Medizin, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".